ArmonAir RespiClick Interactions
There are 112 drugs known to interact with ArmonAir RespiClick (fluticasone), along with 6 disease interactions. Of the total drug interactions, 37 are major, 59 are moderate, and 16 are minor.
- View all 112 medications that may interact with ArmonAir RespiClick
- View ArmonAir RespiClick disease interactions (6)
Most frequently checked interactions
View interaction reports for ArmonAir RespiClick (fluticasone) and the medicines listed below.
- aclidinium
- Advair Diskus (fluticasone / salmeterol)
- Advair HFA (fluticasone / salmeterol)
- AirDuo Respiclick (fluticasone / salmeterol)
- Alvesco (ciclesonide)
- Anoro Ellipta (umeclidinium / vilanterol)
- Arcapta (indacaterol)
- Asmanex HFA (mometasone)
- Asmanex Twisthaler (mometasone)
- Atrovent HFA (ipratropium)
- beractant
- Bethkis (tobramycin)
- Bevespi Aerosphere (formoterol / glycopyrrolate)
- Breo Ellipta (fluticasone / vilanterol)
- Cayston (aztreonam)
- ciclesonide
- Cinqair (reslizumab)
- colistimethate
- Combivent (albuterol / ipratropium)
- Combivent Respimat (albuterol / ipratropium)
- Daliresp (roflumilast)
- dornase alfa
- Dulera (formoterol / mometasone)
- Fasenra (benralizumab)
- ProAir RespiClick (albuterol)
- Qvar RediHaler (beclomethasone)
- Spiriva Respimat (tiotropium)
- Stiolto Respimat (olodaterol / tiotropium)
- Trelegy Ellipta (fluticasone / umeclidinium / vilanterol)
- Utibron Neohaler (glycopyrrolate / indacaterol)
ArmonAir RespiClick disease interactions
There are 6 disease interactions with ArmonAir RespiClick (fluticasone) which include:
- hepatic impairment
- infections
- ocular herpes simplex
- ocular toxicities
- osteoporosis
- hyperadrenocorticism
Report options
More about ArmonAir RespiClick (fluticasone)
- ArmonAir RespiClick consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: inhaled corticosteroids
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Xolair
Xolair injection (omalizumab) is used to help improve allergic asthma, nasal polyps, and chronic ...
Symbicort
Symbicort (budesonide and formoterol) is used to prevent bronchospasm in people with asthma or ...
Dupixent
Dupixent is used to treat eczema, eosinophilic or oral-corticosteroid-dependent asthma, chronic ...
Ventolin HFA
Ventolin HFA (albuterol) is used to treat or prevent breathing problems in patients who have asthma ...
Ventolin
Ventolin is used for asthma, acute, asthma, maintenance, bronchiectasis, bronchospasm prophylaxis ...
Breo Ellipta
Breo Ellipta (fluticasone and vilanterol) is used to prevent airflow obstruction or bronchospasm in ...
Spiriva
Spiriva (tiotropium) is used to prevent bronchospasm in people with bronchitis, emphysema, or COPD ...
Xopenex
Xopenex is a short-acting bronchodilator used to treat or prevent bronchospasm in asthma and other ...
Dulera
Dulera Inhalers (formoterol and mometasone) are used to treat asthma. Includes Dulera side effects ...
Spiriva Respimat
Spiriva Respimat is used for asthma, maintenance, COPD, Maintenance
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.